chronic
viral
infect
import
worldwid
health
concern
global
approxim
million
peopl
chronic
infect
hepat
b
viru
hbv
million
infect
hepat
c
viru
hcv
million
infect
human
immunodefici
viru
hiv
virus
lead
persist
infect
dysfunct
adapt
although
hcv
infect
cure
antivir
therapi
treatment
hiv
hbv
result
complet
clearanc
viru
therefor
patient
must
take
antivir
drug
everi
day
prevent
sever
clinic
problem
aid
endstag
liver
thu
identifi
new
strategi
result
complet
control
viru
one
main
goal
basic
research
one
import
reason
immun
dysfunct
abrog
function
virusspecif
cell
typic
cell
dysfunct
cell
lose
abil
prolifer
produc
cytokin
tumor
necrosi
tnf
effector
memori
function
also
substanti
lost
next
cell
undergo
apoptosi
elimin
phagocyt
cell
hierarch
manner
call
cell
stimul
cell
receptor
tcr
trigger
phosphoryl
signal
activ
multipl
effector
pathway
also
ensur
cell
respond
appropri
signal
famili
member
mostli
costimulatori
provid
activ
signal
via
besid
posit
activ
neg
regul
program
cell
death
cell
immunoglobulin
mucin
domain
contain
signal
via
tcr
variou
cell
surfac
import
inhibitori
receptor
induc
exhaust
cell
engag
ligand
produc
signal
inhibit
cell
prolifer
blockad
restor
function
exhaust
cell
therefor
use
treat
diseas
profit
restor
cell
clinic
success
blockad
human
current
research
focus
discoveri
checkpoint
regul
cell
carcinoembryon
antigenrel
cell
adhes
molecul
biliari
glycoprotein
member
carcinoembryon
antigen
cea
famili
engag
commun
affect
variou
signal
transduct
process
associ
cell
activ
prolifer
differenti
usual
act
via
intercellular
adhes
ndomainmedi
homophil
heterophil
despit
numer
function
express
broad
rang
cell
type
microvascular
endothelia
epitheli
cell
immun
cell
includ
b
cell
macrophag
dendrit
cell
tumor
mice
develop
long
isoform
contain
two
immunoreceptor
tyrosinebas
inhibitori
motif
itim
therefor
believ
inhibitori
suppress
activ
variant
undergo
dimer
depend
intracellular
calcium
interestingli
long
short
cytoplasm
variant
provid
inhibitori
activatori
alon
absenc
also
shown
promot
induct
regulatori
cell
follicular
helper
cell
tfh
cell
contrast
shown
interact
therebi
suppress
cell
besid
direct
involv
phosphoryl
calcium
signal
interact
filamin
therefor
modul
topolog
signal
cell
filamin
interact
lymphocytespecif
protein
kinas
lck
therefor
import
molecul
modul
membran
rearrang
cell
whether
interact
filamin
cell
therebi
contribut
cell
function
remain
unknown
studi
describ
use
lcmv
mous
model
demonstr
express
virusspecif
cell
absenc
cell
limit
cell
expans
function
result
viral
persist
absenc
lead
decreas
tcr
activ
limit
phosphoryl
protein
kinas
phospholipas
extracellular
signalregul
kinas
erk
mechanist
fundament
recruit
lck
immunolog
synaps
notabl
treatment
antibodi
stabil
lck
immunolog
synaps
restor
function
exhaust
cell
mice
lcmv
strain
caus
acut
infect
clear
within
week
effici
induct
virusspecif
cytotox
lymphocyt
ctl
wherea
higher
dose
lcmv
strain
docil
persist
supplementari
fig
caus
chronic
infect
persist
obtain
insight
potenti
role
cell
respons
chronic
viral
infect
challeng
wildtyp
wt
mice
viral
dose
lead
persist
infect
lcmvdocil
measur
express
virusspecif
cell
peripher
cell
exhibit
littl
express
fig
left
panel
infect
lcmvdocil
cell
also
express
higher
level
express
level
highest
day
infect
fig
right
panel
howev
day
infect
fraction
virusspecif
cell
stain
posit
fig
right
panel
elucid
function
cell
viral
infect
challeng
wt
mice
plaqueform
unit
pfu
lcmvdocil
absenc
led
reduc
expans
virusspecif
cell
blood
measur
major
histocompat
mhc
tetram
fig
similarli
number
cell
percentag
virusspecif
cell
reduc
peripher
organ
blood
mice
day
infect
pfu
lcmvdocil
fig
similar
trend
observ
upon
infect
pfu
lcmvdocil
higher
antigen
load
led
gradual
decreas
total
number
cell
percentag
virusspecif
cell
wt
mice
infect
pfu
lcmvdocil
compar
mice
infect
pfu
lcmvdocil
fig
supplementari
fig
absenc
also
caus
loss
cell
function
product
virusspecif
cell
fig
supplementari
fig
total
cell
supplementari
fig
blunt
mice
vitro
restimul
splenocyt
virusspecif
peptid
find
clearli
suggest
remain
virusspecif
cell
mice
produc
reduc
amount
fig
line
find
median
fluoresc
intens
level
virusspecif
cell
fig
total
cell
supplementari
fig
also
reduc
mice
infect
pfu
lcmvdocil
vitro
restimul
splenocyt
virusspecif
peptid
wt
mice
increas
antigen
load
decreas
percentag
virusspecif
cell
product
restimul
lead
cell
exhaust
fig
supplementari
fig
howev
mice
cell
function
impair
infect
either
amount
lcmvdocil
pfu
ratio
percentag
cell
percentag
cell
reduc
almost
equal
independ
antigen
load
find
suggest
lack
render
cell
sensit
exhaust
fig
surfac
express
associ
releas
lytic
granul
protein
granzym
b
perforin
surrog
marker
degranulationdepend
howev
express
total
cell
cell
effector
phenotyp
virusspecif
cell
higher
mice
wt
mice
supplementari
fig
also
product
cytolyt
granul
granzym
b
slightli
higher
virusspecif
cell
mice
wt
mice
supplementari
fig
lcmv
infect
abil
elimin
infect
cell
depend
primarili
cell
reduc
cell
expans
function
mice
associ
impair
control
viru
viral
titer
significantli
higher
peripher
organ
serum
mice
day
infect
wherea
wt
mice
exhibit
undetect
significantli
lower
level
infecti
particl
fig
next
determin
whether
absenc
restrict
expans
cell
acut
viral
infect
infect
wt
mice
pfu
lcmv
strain
total
number
cell
virusspecif
cell
expans
supplementari
fig
intracellular
cytokin
tnf
product
supplementari
fig
limit
mice
day
infect
nevertheless
mice
abl
control
infect
pfu
lcmvwe
day
infect
supplementari
fig
altogeth
conclud
express
essenti
induct
expans
function
virusspecif
cell
control
chronic
viral
infect
control
lcmv
depend
interplay
sever
innat
adapt
immun
cell
special
import
margin
zone
macrophag
margin
zone
metallophil
captur
lcmv
within
minut
therebi
margin
zone
macrophag
prevent
viral
spread
peripher
tissu
contribut
activ
innat
adapt
immun
system
compar
wt
mice
mice
show
aberr
splenic
architectur
remark
reduct
number
total
b
cell
margin
zone
macrophag
fig
lack
macrophag
well
reduc
number
b
cell
may
contribut
insuffici
virusspecif
cell
respons
mice
therefor
hypothes
may
also
play
cellintrins
role
virusspecif
cell
determin
whether
reduc
expans
cell
mice
associ
reduc
prolifer
surviv
activ
cell
cross
wt
mice
mice
carri
tcr
transgen
adopt
transfer
carboxyfluorescein
succinimidyl
ester
cfse
label
wt
splenocyt
wt
host
anim
infect
lcmvdocil
activ
transfer
virusspecif
cell
induc
prolifer
compar
wt
cell
fig
therefor
conclud
induct
prolifer
independ
express
howev
lack
limit
surviv
cell
activ
demonstr
find
number
transfer
cell
significantli
lower
wt
cell
fig
determin
whether
act
directli
expans
cell
activ
transfer
equal
number
wt
splenocyt
wt
host
anim
infect
pfu
lcmvdocil
fig
found
cell
exhibit
less
expans
control
wt
cell
fig
find
may
due
poor
surviv
cell
activ
similarli
cell
exhibit
limit
product
vitro
restimul
peptid
fig
reduct
cell
expans
product
associ
enhanc
viral
titer
spleen
lung
liver
serum
day
infect
fig
determin
whether
defici
affect
develop
cell
vivo
examin
thymic
splenic
cell
subpopul
wt
mice
supplementari
fig
found
defici
import
impact
either
absolut
thymic
cell
number
develop
doubleposit
thymocyt
supplementari
fig
howev
number
matur
cell
lower
mice
wt
mice
line
observ
observ
lower
number
matur
cell
spleen
mice
supplementari
fig
spleen
wt
mice
therefor
conclud
affect
gener
matur
cell
possibl
constrain
tcrdepend
thymicposit
select
process
determin
whether
effect
cell
independ
viral
infect
use
mix
bone
marrow
chimera
produc
irradi
wt
mice
reconstitut
immun
system
bone
marrow
wt
mice
wt
mix
mice
wt
mice
mix
mice
line
result
found
mice
found
exert
slight
influenc
cell
number
peripher
blood
bone
marrowreconstitut
mice
fig
addit
day
infect
fig
pfu
fig
lcmvdocil
virusspecif
cell
blood
spleen
lymph
node
second
group
mice
deriv
mainli
wt
mice
conclud
signal
intrins
cell
essenti
activ
surviv
virusspecif
cell
taken
togeth
find
indic
cellintrins
express
essenti
surviv
effici
expans
cell
viral
infect
next
aim
examin
molecular
mechan
influenc
cell
expans
report
interact
filamin
src
famili
kinas
lck
immunolog
recruit
immunolog
synaps
tcr
activ
promot
membran
rearrang
lead
cytoskelet
chang
organ
thu
either
absenc
activ
defici
lck
result
limit
phosphoryl
interestingli
cytoplasm
domain
interact
filamin
thu
postul
may
involv
recruit
lck
tcr
signal
complex
test
hypothesi
incub
bone
marrowderiv
dendrit
cell
bmdc
wt
mice
cell
wt
mice
wt
cell
form
immunolog
synaps
dc
fig
wherea
cell
interact
dc
fail
recruit
lck
filamin
tcr
signal
complex
fig
determin
whether
reduc
lck
recruit
associ
reduc
tcr
signal
purifi
splenic
cell
wt
mice
activ
combin
antibodi
cell
exhibit
limit
phosphoryl
fig
find
suggest
inde
act
directli
lck
upstream
tcr
activ
pathway
reduc
phosphoryl
absenc
still
allow
initi
prolifer
cell
result
reduc
surviv
prolifer
cell
antigen
activ
fig
b
next
determin
whether
lck
recruit
affect
exhaust
cell
whether
could
restor
function
treatment
antibodi
hypothes
treatment
antibodi
stabil
filamin
lck
within
tcr
signal
complex
test
idea
cultur
purifi
wt
cell
presenc
activ
exhaust
dose
peptid
higher
antigen
load
lead
deterior
cell
function
turn
lead
express
variou
inhibitori
receptor
surfac
compar
wt
cell
receiv
activ
dose
peptid
cultur
wt
cell
receiv
exhaust
dose
peptid
exhibit
higher
express
inhibitori
receptor
lymphocyteactiv
gene
protein
supplementari
fig
also
exhibit
reduc
function
term
product
tnf
supplementari
fig
vitro
restimul
peptid
cell
group
also
stain
posit
express
surfac
supplementari
fig
activ
exhaust
cell
incub
dc
day
activ
cell
recruit
lck
filamin
immunolog
synaps
fig
first
line
contrast
exhaust
cell
receiv
isotyp
immunoglobulin
g
igg
monoclon
antibodi
mab
fig
second
line
tcrindepend
stimulu
mab
fig
third
line
incub
dc
fail
recruit
lck
immunolog
synaps
hand
mab
clone
ad
exhaust
cell
incub
dc
recruit
lck
immunolog
synaps
restor
fig
fourth
line
find
show
essenti
recruit
lck
tcr
signal
complex
form
immunolog
synaps
tcr
signal
enhanc
treatment
mab
next
examin
whether
treatment
mab
could
modul
function
virusspecif
cell
vivo
inject
wt
mice
isotyp
control
mab
mab
clone
infect
pfu
lcmvdocil
fig
treatment
mab
increas
number
virusspecif
cell
measur
tetram
fig
enhanc
number
viral
infect
resolv
rapidli
fig
effici
cell
function
rapid
clearanc
viru
caus
less
damag
liver
hepatocyt
result
reduc
immunopatholog
measur
activ
liverspecif
enzym
alanin
transaminas
alt
aspart
transaminas
ast
mice
treat
mab
supplementari
fig
next
investig
whether
mab
treatment
use
therapeut
ongo
viral
infect
infect
wt
mice
lcmvdocil
therebi
establish
chronic
viral
infect
mice
day
infect
one
group
mice
treat
isotyp
control
mab
wherea
separ
group
mice
treat
mab
fig
mice
treat
mab
exhibit
lower
viral
load
mice
treat
isotyp
mab
fig
determin
whether
treatment
mab
act
specif
cell
transfer
equal
number
wt
splenocyt
mice
treat
mice
mab
isotyp
mab
follow
lcmvdocil
infect
fig
found
treatment
mab
enhanc
virusspecif
cell
respons
numer
fig
also
function
abil
produc
fig
viral
titer
significantli
reduc
sever
organ
treatment
mab
day
infect
fig
togeth
find
suggest
treatment
antibodi
enhanc
function
cell
quantit
also
qualit
therebi
restor
function
exhaust
cell
chronic
viral
infect
next
determin
whether
mab
could
use
enhanc
function
virusspecif
cell
human
peripher
blood
mononuclear
cell
pbmc
test
bind
human
mab
clone
made
inhous
cell
healthi
donor
antihuman
antibodi
exhibit
bind
cell
fig
determin
whether
antibodi
could
enhanc
cell
function
cultur
pbmc
healthi
donor
antibodi
presenc
influenza
flu
peptid
gilgfvftl
without
mab
found
mab
enhanc
product
cell
restimul
flu
peptid
fig
similarli
pbmc
healthi
donor
exhibit
higher
product
cultur
cytomegaloviru
cmv
peptid
nlvpmvatv
presenc
mab
fig
determin
whether
mab
also
improv
function
cell
vivo
use
mous
model
express
human
transgen
newli
gener
mice
exhibit
splenic
structur
resembl
wt
mice
fig
express
substanti
level
peripher
blood
cell
fig
treat
mice
antibodi
infect
lcmvdocil
fig
treatment
mab
enhanc
virusspecif
cell
number
fig
number
tetramerspecif
cell
significantli
higher
mabtreat
mice
isotyp
control
mabtreat
mice
moreov
number
tetramerspecif
cell
slightli
higher
mice
treat
mab
mice
treat
isotyp
control
mab
fig
therefor
conclud
treatment
mab
improv
virusspecif
cell
number
function
vitro
vivo
report
describ
involv
chronic
viral
infect
found
lack
correl
defici
control
lcmv
certainli
reduc
number
b
cell
margin
zone
macrophag
contribut
defici
control
lcmv
focus
cellintrins
role
cell
absenc
cell
result
insuffici
cell
function
conduct
adapt
cell
transfer
experi
found
cellintrins
defici
result
reduc
viral
control
spleen
lymph
node
lung
liver
serum
therefor
absenc
within
cell
contribut
lack
viral
control
mice
mechanist
found
defici
within
cell
associ
limit
tcr
activ
involv
recruit
lck
immunolog
synaps
therebi
promot
phosphoryl
addit
absenc
ceacam
influenc
prolifer
cell
affect
surviv
prolifer
cell
activ
line
find
gener
matur
thymocyt
slightli
reduc
absenc
howev
differ
less
pronounc
gener
virusspecif
cell
absenc
divers
function
immun
system
describ
primarili
regul
cell
express
inhibit
cell
prolifer
therebi
prevent
inflammatori
bowel
diseas
wherea
express
essenti
develop
tfhdriven
iga
product
gut
b
recent
found
express
b
cell
enhanc
syk
phosphoryl
b
cell
receptor
activ
therefor
essenti
b
cell
develop
surviv
line
data
express
maintain
splenic
architectur
includ
develop
b
cell
follicl
metallophil
b
cell
margin
zone
macrophag
play
import
role
lcmv
macrophag
specif
play
integr
function
prevent
earli
viral
propag
immedi
therefor
like
addit
reduc
cell
function
reduc
number
margin
zone
macrophag
contribut
defect
lcmv
control
mice
current
find
show
express
cell
enhanc
tcr
signal
virusspecif
cell
via
recruit
lck
immunolog
synaps
accord
klail
et
convinc
interact
long
isoform
exhaust
cell
stabil
lck
activ
restor
exhaust
cell
addit
bind
mab
variou
extracellular
domain
finetun
activatori
signal
upon
ligat
therefor
identifi
import
player
activ
cell
persist
viral
infect
treatment
antibodi
enhanc
lcmvspecif
cell
expans
prolifer
also
control
chronic
infect
within
week
wherea
chronic
infect
persist
control
anim
administr
antibodi
improv
number
product
virusspecif
cell
vitro
virusspecif
human
ctl
vivo
human
transgen
mous
model
propos
treat
cell
antibodi
stabil
lck
within
tcr
signal
complex
lcmv
infect
mechan
could
add
recent
describ
interact
antibodi
block
interact
therebi
limit
itim
phosphoryl
result
prolong
tcr
addit
simultan
block
pathway
restor
cell
function
result
better
control
whether
mechan
contribut
activ
effect
found
current
studi
remain
investig
current
studi
found
chronic
viral
infect
activ
strongli
improv
antivir
cell
respons
resolv
viral
infect
also
virusspecif
human
cell
strongli
activ
treatment
speciesspecif
antibodi
obvious
remain
unknown
whether
treatment
antibodi
variou
type
viral
infect
autoimmun
diseas
cancer
could
similarli
benefit
cell
function
basi
find
specul
whenev
recruit
lck
immunolog
synapsi
limit
treatment
would
improv
cell
function
could
improv
success
vaccin
conclus
found
import
player
resolv
acut
chronic
viral
infect
treatment
chronic
viral
infect
antibodi
enhanc
antivir
cell
respons
variou
effect
immun
compon
may
also
benefit
therapeut
approach
respect
rapid
control
viral
infect
use
antibodi
combat
chronic
viral
infect
appear
power
therapeut
option
mice
use
studi
includ
wt
mice
maintain
genet
background
backcross
mani
time
bred
homozygot
mice
kindli
provid
prof
nicol
beauchemin
rosalind
morri
goodman
cancer
centr
montreal
qc
canada
human
transgen
mice
origin
develop
kindli
provid
prof
j
shive
beckman
research
institut
citi
hope
duart
ca
usa
backcross
eight
time
background
cross
eight
time
mice
gener
mice
establish
one
author
b
b
adopt
transfer
experi
mice
congen
use
distinguish
transfer
cell
endogen
cell
wt
wt
mice
express
cell
receptor
transgen
use
cell
transfer
studi
sixweekold
eightweekold
agematch
sexmatch
mice
use
experi
anim
hous
singl
ventil
cage
anim
experi
author
nordrhein
westfalen
landesamt
natur
umwelt
und
verbraucherschutz
recklinghausen
germani
accord
german
law
anim
protect
lcmvwe
origin
obtain
f
lehmanngrub
heinrich
pett
institut
hamburg
germani
propag
cell
obtain
atcc
nctc
clone
lcmvdocil
donat
prof
dr
r
zinkernagel
univers
zurich
zurich
switzerland
propag
cell
mice
infect
intraven
either
pfu
lcmvdocil
lcmvwe
lcmv
viral
titer
detect
plaqueform
assay
fibroblast
previous
brief
organ
smash
dulbecco
modifi
eagl
medium
dmem
contain
fetal
calf
serum
fc
titrat
step
roundbottom
plate
plaqu
cell
incub
h
overlay
ad
mixtur
methyl
cellulos
iscov
modifi
dulbecco
medium
viru
prepar
incub
plaqu
count
h
later
lcmv
nucleoprotein
np
stain
stain
cell
fix
formaldehyd
solut
phosphatebuff
salin
pb
permeabil
tritonx
solut
pb
block
fc
pb
stain
rabbit
antilcmv
np
antibodi
made
inhous
enhanc
chemiluminescenceconjug
antirabbitigg
antibodi
jackson
immunoresearch
use
secondari
antibodi
dilut
origin
concentr
distil
water
plaqu
detect
chemiluminesc
citric
acid
ophenylenediamin
dihydrochlorid
chemic
sigmaaldrich
tetram
provid
tetram
facil
nation
institut
health
nih
bethesda
md
usa
cell
stain
allophycocyaninlabel
mhc
class
tetram
min
incub
sampl
stain
ebiosci
antibodi
clone
kind
gift
dr
kathryn
v
holm
univers
colorado
denver
co
usa
min
blood
sampl
erythrocyt
lyse
ml
bd
lyse
solut
bd
bioscienc
wash
fluorescenceactiv
cell
sort
fac
buffer
analyz
flow
cytometri
absolut
number
cell
calcul
fac
analysi
use
fluoresc
bead
bd
bioscienc
measur
intracellular
tnf
cell
fix
formaldehyd
formaldehyd
solut
pb
min
permeabil
saponin
solut
stain
xmg
tnf
antibodi
ebiosci
splenocyt
transfer
experi
cell
stain
describ
addit
cell
stain
antibodi
ebiosci
human
peripher
blood
cell
stain
ebiosci
clone
provid
one
author
bb
made
label
inhous
ebiosci
antibodi
correspond
isotyp
label
inhous
ebiosci
antibodi
check
express
surfac
marker
cultur
cell
stain
invitrogen
ebiosci
biolegend
ebiosci
antibodi
antibodi
dilut
origin
concentr
fac
buffer
determin
total
cell
number
fac
bead
use
bd
bioscienc
stain
cell
analyz
lsr
ii
fac
fortessa
flow
cytomet
bd
bioscienc
data
analyz
flowjo
softwar
flowjo
llc
ashland
usa
intracellular
cytokin
stain
ic
splenic
tissu
homogen
splenocyt
restimul
peptid
polypeptid
laboratori
strasbourg
franc
h
brefeldin
bfa
ad
h
stimul
sampl
incub
incub
surfac
intracellular
marker
describ
human
pbmc
cultur
day
media
contain
iu
roch
peptid
flu
gilgfvftl
cmv
nlvpmvatv
iba
lifesci
goettingen
germani
presenc
absenc
antibodi
clone
day
cell
restimul
flu
cmv
peptid
presenc
bfa
h
subject
variou
type
stain
surfac
intracellular
marker
describ
human
pbmc
collect
healthi
donor
process
buffi
coat
obtain
center
blood
donat
univers
hospit
written
inform
consent
obtain
particip
studi
approv
ethic
committe
univers
hospit
studi
number
sampl
anonym
addit
donor
inform
avail
cell
surfac
stain
determin
ctl
activ
perform
bd
reagent
short
cell
antibodi
bd
bioscienc
use
surfac
stain
dead
cell
propidium
iodideposit
exclud
cell
surfac
analysi
intracellular
granzym
b
caltag
laboratori
stain
perform
cytofixcytoperm
intracellular
stain
kit
bd
bioscienc
stimul
splenocyt
bd
bioscienc
antibodi
describ
splenocyt
wt
mice
express
congen
marker
inject
intraven
wt
mice
wt
mice
one
day
later
mice
infect
pfu
lcmvdocil
percentag
actual
number
prolifer
cell
assess
variou
compart
flow
cytometri
day
infect
puriti
sort
cell
maintain
higher
transfer
cell
prolifer
assay
cell
label
cfse
splenocyt
per
mous
transfer
recipi
mice
prolifer
assess
flow
cytometri
data
analyz
flowjo
softwar
gener
bone
marrow
chimera
wt
mice
irradi
total
rad
h
immun
system
mice
reconstitut
intraven
bone
marrow
cell
donor
mix
bone
marrow
chimera
mice
analyz
day
reconstitut
spleen
dissoci
cell
purifi
pan
cell
isol
kit
magneticactiv
cell
sort
mac
miltenyi
biotech
accord
standard
techniqu
mac
column
next
cell
challeng
without
combin
antibodi
bd
bioscienc
variou
time
period
cell
lyse
boil
sodium
dodecyl
sulfat
sd
buffer
sd
glycerol
tri
ph
sigma
total
cell
extract
examin
sdspolyacrylamid
gel
electrophoresi
gel
transfer
onto
whatman
nitrocellulos
membran
ge
healthcar
accord
standard
techniqu
membran
block
h
bovin
serum
albumin
bsa
paa
laboratori
pb
supplement
incub
follow
antibodi
syk
antisyk
cell
signal
technolog
secondari
antibodi
antigapdh
meridian
life
scienc
detect
horseradish
peroxidaseconjug
antimous
igg
antibodi
biorad
laboratori
antirabbit
igg
antibodi
ge
healthcar
signal
detect
biorad
chemidoc
imag
system
biorad
laboratori
analyz
manufactur
softwar
imag
crop
purpos
present
intraven
inject
antimous
antibodi
clone
antibodi
clone
isotyp
control
mab
mous
day
day
infect
respect
primari
dc
gener
isol
bone
marrow
cell
femur
tibia
mice
follow
elimin
erythrocyt
bone
marrow
cell
cultur
low
endotoxindmem
biochrom
supplement
v
lipopolysaccharid
lp
free
fc
biochrom
v
penicillinstreptomycinglutamin
thermo
fisher
scientif
v
mm
invitrogen
ng
colonystimul
factor
made
inhous
cell
treat
lipopolysaccharid
ng
sigmaaldrich
h
day
day
harvest
cell
wash
dulbecco
phosphatebuff
salin
dpb
cell
transfer
plate
contain
coverslip
coat
polyllysin
sigmaaldrich
cell
purifi
cell
isol
kit
mac
miltenyi
biotech
accord
standard
techniqu
spleen
homogen
mac
buffer
fc
ethylenediaminetetraacet
acid
dpb
histolog
analysi
coverslip
coat
polyllysin
solut
sigmaaldrich
min
dc
ad
cell
load
peptid
incub
h
intermitt
shake
cell
wash
dpb
equal
number
purifi
cell
ad
purifi
cell
cultur
iscov
modifi
dulbecco
medium
lonza
supplement
v
lpsfree
fc
biochrom
v
penicillinstreptomycin
thermo
fisher
scientif
v
mm
invitrogen
min
incub
cell
wash
dpb
fix
formaldehyd
dpb
permeabil
tritonx
dpb
nonspecif
antigen
block
bsa
dpb
min
cell
stain
antilck
santa
cruz
biotechnolog
antifilamin
abcam
dapi
invitrogen
antibodi
fluoresc
label
antimous
thermo
fisher
scientif
antigoat
invitrogen
secondari
antibodi
use
detect
signal
antibodi
dilut
origin
concentr
block
solut
incub
min
room
temperatur
vitro
activ
exhaust
cell
purifi
cell
cultur
media
describ
next
cell
activ
addit
peptid
day
exhaust
addit
peptid
cultur
media
day
isotyp
igg
clone
biolegend
clone
mab
ad
min
along
activ
exhaust
cell
imag
stain
section
acquir
confoc
microscop
leica
gsted
leica
microsystem
zoom
object
imari
softwar
bitplan
ag
zurich
switzerland
use
reconstruct
histolog
analys
snapfrozen
tissu
perform
mab
ebiosci
biotin
acri
antibodi
use
stain
macrophag
section
wash
stain
streptavidin
antibodi
ebiosci
short
section
fix
aceton
min
nonspecif
antigen
bind
block
pb
contain
fc
min
follow
stain
variou
antibodi
min
antibodi
dilut
origin
concentr
block
solut
imag
stain
section
acquir
fluoresc
microscop
keyenc
bz
ii
analyz
keyenc
corpor
america
itasca
il
usa
activ
alt
ast
measur
central
laboratori
univers
hospit
essen
germani
data
express
mean
sem
independ
experi
student
test
use
detect
statist
signific
differ
group
sampl
valu
exclud
analysi
level
statist
signific
set
p
graph
prepar
graphpad
prism
graphpad
softwar
la
jolla
ca
usa
data
support
find
studi
avail
correspond
author
upon
request
